Cell Death and Clonal Survival in Myelodysplastic Syndr*
骨髓增生异常综合征中的细胞死亡和克隆存活*
基本信息
- 批准号:7022676
- 负责人:
- 金额:$ 43.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-15 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:NOD mouseSCID mouseagingapoptosisbiological signal transductionbone marrow disordercell deathcell linecell proliferationclinical researchgene expressionhematopoietic stem cellshuman subjectmolecular cloningnuclear factor kappa betapathologic processprotein structure functiontissue /cell culturetumor necrosis factor alpha
项目摘要
DESCRIPTION (provided by applicant):
The Myelodysplastic Syndrome (MDS) is predominantly a disease of older age, and with the aging of the population, an increase in cases is expected. Our proposal is aimed at improving our understanding of the pathophysiology of MDS, and to identify cellular or molecular targets suitable for novel treatment strategies. MDS is a clonal disorder of hematopoietic stem cells; however, there is evidence that factors in the microenvironment contribute to the propagation of the disease. Thus, we propose to characterize interactions between the marrow microenvironment and hematopoietic precursors and identify signaling pathways that determine programmed cell death (apoptosis) and clonal survival. Specifically, we will 1) define stroma-dependent activities that affect survival/expansion of clonal and non-clonal hematopoietic precursors from MDS marrow. In an in vitro system using myeloid cell lines and primary MDS cells, we will characterize the functional relevance of tumor necrosis factor (TNF)alpha-induced alterations in gene expression in stroma for the support of clonal or non-clonal hematopoietic precursors (TNFalpha is upregulated in MDS). In a xenogeneic in vivo model we will determine the role of human stroma for the survival of MDS-derived clones transplanted into mice. We will 2) characterize apoptotic and proliferative events in MDS marrow and correlate these with disease progression. We will define interactions of TNFalpha-initiated signals that control apoptosis and proliferation, in particular, the roles of NFkappaB and the anti-apoptotic molecule, FLIP. Preliminary in vitro data show that overexpression of FLIP enhances cell survival. We will now determine in vivo whether genetic modification of FLIP expression in MDS cells transplanted in immunodeficient mice affects survival and allows for expansion of the clone. The techniques involved in pursuit of our objectives include in vitro assays of hematopoiesis, apoptosis, and proliferation in in vitro culture systems. The relevance of in vitro findings will be validated in vivo in a xenogeneic transplant model of cell lines and primary MDS cells in immunodeficient mice in which propagation of normal and clonal cells will be characterized. By using interventions that block relevant signals or by genetically modifying molecules that play pivotal roles, we will identify potential targets for novel therapeutic strategies. The human population is aging, and the incidence of MDS increases with age. Novel treatment approaches are needed that are tolerated by older individuals and, hopefully, will not interfere with their quality of life. To achieve these objectives, we must better understand the underlying mechanisms of MDS and thereby identify ways by which the disease process can be arrested, progression prevented, and the disease hopefully be cured.
描述(由申请人提供):
骨髓增生性综合征(MDS)主要是年龄较大的疾病,随着人口的老龄化,预计病例会增加。我们的建议旨在提高我们对MD的病理生理学的理解,并确定适合新型治疗策略的细胞或分子靶标。 MDS是造血干细胞的克隆疾病。但是,有证据表明,微环境中的因素有助于疾病的传播。因此,我们建议表征骨髓微环境和造血前体之间的相互作用,并确定确定程序性细胞死亡(凋亡)和克隆存活率的信号传导途径。具体而言,我们将1)定义基质依赖性活性,这些活性影响了MDS骨髓的克隆和非克隆造血前体的存活/膨胀。在使用髓样细胞系和原代MDS细胞的体外系统中,我们将表征肿瘤坏死因子(TNF)α诱导基因表达中基因表达的变化的功能相关性,以支持克隆或非锁骨血肿前体的支持(TNFALPHA在MDS中上调)。在异构体内模型中,我们将确定人基质在移植到小鼠中的MDS衍生克隆存活中的作用。我们将2)表征MDS骨髓中的凋亡和增殖事件,并将其与疾病进展相关。我们将定义tnfalpha引起的信号的相互作用,这些信号控制着凋亡和增殖,特别是NFKAPPAB和抗凋亡分子的作用,Flip。 初步的体外数据表明,翻转的过表达可增强细胞存活。现在,我们将在体内确定在免疫缺陷小鼠中移植的MDS细胞中FLIP表达的遗传修饰是否会影响存活并允许克隆的扩展。追求我们目标的技术包括体外造血,凋亡和体外培养系统中增殖的测定。体外发现的相关性将在体内验证在免疫缺陷小鼠中的细胞系和原代MDS细胞的异构移植模型中,其中将表征正常细胞和克隆细胞的传播。通过使用阻断相关信号或通过基因修饰发挥关键作用的分子的干预措施,我们将确定新型治疗策略的潜在靶标。 人口正在衰老,MDS的发病率随着年龄的增长而增加。需要新颖的治疗方法,这些方法被老年人所容忍的,希望不会干扰其生活质量。为了实现这些目标,我们必须更好地理解MDS的潜在机制,从而确定可以逮捕疾病过程,预防进展并希望治愈疾病的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H. JOACHIM DEEG其他文献
H. JOACHIM DEEG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H. JOACHIM DEEG', 18)}}的其他基金
Hematopoietic Cell Transplantation and Iron Overload
造血细胞移植和铁过载
- 批准号:
7888104 - 财政年份:2010
- 资助金额:
$ 43.25万 - 项目类别:
Hematopoietic Cell Transplantation and Iron Overload
造血细胞移植和铁过载
- 批准号:
8235938 - 财政年份:2010
- 资助金额:
$ 43.25万 - 项目类别:
Hematopoietic Cell Transplantation and Iron Overload
造血细胞移植和铁过载
- 批准号:
8055465 - 财政年份:2010
- 资助金额:
$ 43.25万 - 项目类别:
Hematopoietic Cell Transplantation and Iron Overload
造血细胞移植和铁过量
- 批准号:
8434139 - 财政年份:2010
- 资助金额:
$ 43.25万 - 项目类别:
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
异基因造血细胞移植治疗骨髓增生异常综合征
- 批准号:
7478450 - 财政年份:2007
- 资助金额:
$ 43.25万 - 项目类别:
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
异基因造血细胞移植治疗骨髓增生异常综合征
- 批准号:
7304858 - 财政年份:2006
- 资助金额:
$ 43.25万 - 项目类别:
Cell Death and Clonal Survival in Myelodysplastic Syndr*
骨髓增生异常综合征中的细胞死亡和克隆存活*
- 批准号:
7278677 - 财政年份:2005
- 资助金额:
$ 43.25万 - 项目类别:
WT1 Expression in Patients with MDS Treated with ATG an*
接受 ATG 治疗的 MDS 患者中 WT1 表达*
- 批准号:
7056452 - 财政年份:2005
- 资助金额:
$ 43.25万 - 项目类别:
Cell Death and Clonal Survival in Myelodysplastic Syndr*
骨髓增生异常综合征中的细胞死亡和克隆存活*
- 批准号:
7487816 - 财政年份:2005
- 资助金额:
$ 43.25万 - 项目类别:
WT1 Expression in Patients with MDS Treated with ATG an*
接受 ATG 治疗的 MDS 患者中 WT1 表达*
- 批准号:
7230026 - 财政年份:2005
- 资助金额:
$ 43.25万 - 项目类别:
相似海外基金
Deciphering the role of mitochondrial/autophagy dysfunction in regulating inflammatory processes during AMD pathogenesis
破译线粒体/自噬功能障碍在 AMD 发病机制中调节炎症过程中的作用
- 批准号:
10664118 - 财政年份:2023
- 资助金额:
$ 43.25万 - 项目类别:
The Role of Dermal Fibroblasts in Skin Cancer
真皮成纤维细胞在皮肤癌中的作用
- 批准号:
10368503 - 财政年份:2022
- 资助金额:
$ 43.25万 - 项目类别:
The Role of Dermal Fibroblasts in Skin Cancer
真皮成纤维细胞在皮肤癌中的作用
- 批准号:
10549747 - 财政年份:2022
- 资助金额:
$ 43.25万 - 项目类别:
Free Fatty Acids, p16 and Pancreatic Beta Cell Proliferation
游离脂肪酸、p16 和胰腺 β 细胞增殖
- 批准号:
8271681 - 财政年份:2012
- 资助金额:
$ 43.25万 - 项目类别:
Free Fatty Acids, p16 and Pancreatic Beta Cell Proliferation
游离脂肪酸、p16 和胰腺 β 细胞增殖
- 批准号:
8441535 - 财政年份:2012
- 资助金额:
$ 43.25万 - 项目类别: